Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Person writing with pen

Psilocybin for depression.

Journal article

De Giorgi R. and Ede R., (2024), BMJ, 385

Ketamine for suicidal ideation

Journal article

De Giorgi R., (2022), BMJ, o74 - o74

Effects of various statins on depressive symptoms: is there enough evidence?

Journal article

De Giorgi R. et al, (2021), Journal of Affective Disorders, 295, 1093 - 1094

Strategies for preventing occupational stress in healthcare workers: Past evidence, current problems

Journal article

De Giorgi R. and Dinkelaar BM., (2021), BJPsych Advances, 27, 205 - 210

Adjunctive benzodiazepines in depression: A clinical dilemma with no recent answers from research

Journal article

De Cates AN. and De Giorgi R., (2020), BJPsych Advances, 26, 321 - 326

Atorvastatin increases fear processing in healthy participants

Conference paper

Martens M. et al, (2020), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 40, S419 - S420

The wh-questions of network meta-analyses

Journal article

De Giorgi R., (2019), BJPsych Advances, 25, 396 - 398

The wh-questions of network meta-analyses

Journal article

De Giorgi R., (2019), BJPsych Advances, 25, 396 - 398

Trainee Leadership Board: Learning about NHS leadership

Journal article

Stegen G. et al, (2018), BMJ Leader, 2, 46 - 48